Wednesday, February 10, 2016 12:23:21 PM
Scientists attack Zika virus from multiple angles
Scientists on the frontlines of the Zika virus battle are closing in on the mosquito-borne illness from multiple angles. Their efforts include fighting the bug with genetically engineered mosquitoes, searching for safer and more effective chemical pesticides, and developing medicines to treat or prevent Zika virus infections. International health officials suspect those infections are linked to increasing rates of birth defects as well as of a nerve disorder that causes paralysis.
“Our intention is to design a vaccine that we can bring to the market relatively rapidly, that will be a single shot vaccine and that will be effective against these new strains of Zika virus that are circulating in the Americas,” Ted Ross, director of the University of Georgia’s (UGA) Center for Vaccines and Immunology, told FoxNews.com.
UGA researchers are collaborating with metro Atlanta-based GeoVax Labs. By using the company’s vaccine platform, which has already been through the Food and Drug Administration (FDA) approval process, Ross said researchers may be able to develop a vaccine in five to seven years— much faster than the normal process, which can take 10 to 20 years.
“For emergency use, a vaccine could be on the market much faster if it’s needed,” Ross said. “It depends on how fast Zika spreads throughout the Americas and into the United States. So, that timeframe could be as short as two years if necessary.”
Meanwhile, the British biotech firm Oxitec is awaiting FDA approval to conduct field trials in the Florida Keys of a mosquito control solution that involves genetic engineering.
The company has produced a modified version of Aedes aegypti, the primary mosquito species that carries the Zika virus. When the modified males are released into the wild, they mate with female mosquitoes and pass on a gene that causes their offspring to die before reaching adulthood.
In field tests already conducted in the Cayman Islands, Malaysia and Brazil, Oxitec reports that its modified mosquitoes reduced the local Aedes aegypti population by more than 90 percent over a period of about six months.
The novel concept has given rise to unproven conspiracy theories, as well as some ecological concerns over the impact of removing a mosquito species from the environment.
Oxitec CEO Hadyn Parry said the wild Aedes aegypti mosquitoes are an invasive species that are not native to the Americas. And the self-limiting gene keeps the modified mosquitoes under control.
“What people perceive is that if you’re putting a new gene into the environment, that it will spread and it will stay there, and there’s no going back,” Parry told FoxNews.com. “Our system, of course, is the exact opposite. It’s self-limiting. It’s a dead end. The mosquitoes don’t survive. So, you can release our mosquitoes into the wild or into a town. And, if you wish to, you could stop and they would actually disappear from the environment. You wouldn’t find them after a few weeks.”
Parry added that conventional mosquito control measures that involve chemical insecticides eradicate multiple insect species.
“Ours is actually much more of a precision instrument,” Parry said of his company’s genetically modified mosquito. “We’re just trying to combat the one species that’s spreading disease at the moment— this Aedes aegypti.”
Recent GOVX News
- GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine • GlobeNewswire Inc. • 04/04/2024 04:30:00 PM
- GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress • GlobeNewswire Inc. • 03/28/2024 01:00:00 PM
- GeoVax to Present at the 36th Annual Roth Conference • GlobeNewswire Inc. • 03/12/2024 01:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/11/2024 08:13:14 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/11/2024 04:15:24 AM
- GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System • GlobeNewswire Inc. • 03/06/2024 02:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/01/2024 09:08:47 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 09:05:14 PM
- GeoVax Reports 2023 Year-End Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:41:26 PM
- GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 • GlobeNewswire Inc. • 02/22/2024 02:00:00 PM
- GeoVax to Present at the 2024 BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/19/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:01:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:25 PM
- GeoVax Announces Multiple Patent Issuances and Allowances • GlobeNewswire Inc. • 02/13/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:43:48 PM
- GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster • GlobeNewswire Inc. • 02/06/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 06:13:27 PM
- GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement • GlobeNewswire Inc. • 01/29/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:03:40 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/12/2024 09:00:38 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM